评论
打印
v. 一瞥，扫视，匆匆一看，反光，闪烁，掠过
您现在的位置： 首页 > 英语听力 > 英语视频听力 > 新闻懒人包 > 正文
- A new study suggests we need to rethink diabetes treatment because of the rising cost of insulin.
- 一项新的研究表明，我们需要重新考虑糖尿病的治疗，因为胰岛素成本的增长。
- The increasing costs have been noted in recent years, with some blaming a lack of "healthy" competition.
- 近年来人们注意到了日益增长的成本，一些人指责缺乏“健康”的竞争。
- The interesting thing about the insulin market is there's really only three companies in the insulin market.
- 关于胰岛素市场有趣的事是，胰岛素市场上真正只有三家公司。
- So it's a very small number of companies. There's no generics, and the prices just seem to go up for these drugs in tandem.
- 所以公司的数量非常小。无非专利药物，而且这些药物价格似乎相继上涨。
- The study, published in JAMA, looked at insulin prices from 2002 to 2013.
- 该研究发表在美国医学会杂志，关注2002年到2013年胰岛素的价格。
- Since 2002, the cost of insulin increased by almost 200 percent — an increase made even more significant by findings that showed the amount of insulin being used per patient also increased.
- 自2002年，胰岛素的价格增加了近百分之200，调查结果显示每名患者使用的胰岛素量也有所增加。
- Medical Xpress suggests the increase in doses could be due to increases in obesity in that time period, and new national recommendations stressing lower sugar intake.
- 医学快讯建议，使用剂量的增加可能是由于这段时间内肥胖的增加，以及新的国家建议强调低糖摄入。
- Researchers predicted "the mean price of insulin is unlikely to decline as a result of generic competition because of the stringent regulations and substantial costs of bringing biosimilar insulins to market."
- 研究人员预测，“胰岛素的平均价格不太可能由于仿制药的竞争下降，因为严格的法规以及引进生物仿制胰岛素进入市场的大量成本。
扫描二维码进行跟读打分训练
- 阅读本文的人还阅读了：
可可英语官方微信(微信号:ikekenet)
每天向大家推送短小精悍的英语学习资料.
添加方式1.扫描上方可可官方微信二维码。
添加方式2.搜索微信号ikekenet添加即可。
添加方式1.扫描上方可可官方微信二维码。
添加方式2.搜索微信号ikekenet添加即可。
